BIOCRATES Life Sciences to introduce AbsoluteIDQ p180 and p150 research kits

Austrian BIOCRATES Life Sciences AG, prime developer of state-of-the-art metabolite biomarker panels, is about to launch new editions of two of its well-established research kit products -AbsoluteIDQ® p180 and p150. Originally developed for use with the AB Sciex mass spectrometers, both kits are now available for Waters Xevo® TQ MS systems,  greatly increasing sample throughput and accelerating up analytical processes.

AbsoluteIDQ® p180 Kit-Waters Xevo® TQ MS edition
Now also running on the ACQUITY UPLC® system by Waters, the new edition of the AbsoluteIDQ  p180 Kit speeds up your research, requiring only 16 hours of measurement time compared with 32 hours for conventional high performance liquid chromatography (HPLC). The Waters UPLC® technology was created especially for scientists who seek a reliable technology that simultaneously improves laboratory productivity, efficiency, and throughput.

Quantifying more than 180 metabolites from key metabolic pathways, the AbsoluteIDQ p180 Kit delivers the widest range of metabolomic information available from a single targeted assay. Analyzed metabolite classes include acylcarnitines, amino acids and biogenic amines, hexose, and sphingo- and glycerophospholipids.

AbsoluteIDQ® p150 Kit-Waters Xevo® TQ MS edition
Also now available for Waters Xevo TQ mass spectrometers is the AbsoluteIDQ p150 Kit, which identifies and quantifies 158 metabolites from 4 compound classes using a FIA-MS/MS method.

Both kits feature the proprietary MetIDQ™ software for the automated calculation of metabolite concentrations, require only small sample volumes of 10 µL, and are suitable for use with a wide range of biological samples.

SOURCE Biocrates Life Sciences AG

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration